Table IA.
Clinical profile of the study patients (March 1st, 2020, and December 22nd, 2020, before available universal vaccination)
| Variables | 30-day mortality N=58 | Alive N=2536 |
|---|---|---|
| Demographics | ||
| Age (years, mean±SD) | 69.3±10.6 | 63.4±10.1 |
| Gender (male) | 41 (66.0%) | 2036 (80.2%) |
| Comorbidities | ||
| Hypertension | 21 (36.2%) | 1039 (41.0%) |
| Type 2 diabetes | 22 (37.9%) | 744 (29.3%) |
| Ischemic heart disease | 37 (63.8%) | 1773 (69.9%) |
| Dyslipidemia | 21 (36.2%) | 1022 (40.3%) |
| Atrial fibrillation | 12 (20.7%) | 344 (13.6%) |
| Obesity | 6 (10.3%) | 275 (10.8%) |
| Procedure | ||
| CABG | 29 (50.0%) | 1682 (66.3%) |
| AVR | 8 (13.8%) | 383 (15.1%) |
| MVR | 7 (12.1%) | 205 (8.1%) |
| CABG+valve | 14 (24.1%) | 266 (10.5%) |